Study Guides (247,929)
Canada (121,167)
Nursing (6)
Final

2550 Advanced Life Sciences Final Exam Review.docx

6 Pages
184 Views
Unlock Document

Department
Nursing
Course
NURS 2550H
Professor
Ellen Buck- Mc Fadyen
Semester
Fall

Description
2550 Advanced Life Sciences Final Exam Review http://www.youtube.com/watch?v=hR4OUviDhSI Pharmacodynamics - Principles of drug action Teratogenesis: o Drug interacts with receptor -> bind to receptor -> response A – remote risk o Drug alters physiological response B – slightly more risk o Drug always has more than one effect C – more risk - Drugs bind to receptors instead of natural ligand D – proven risk o Mimic neurotransmitter, trick the body into allowing the drug to bind X - CONTRAINDICATION - D (drug) R(receptor)D – R Complex  Response - Receptor function is normally regulated by molecules supplied by the body - A drug cannot make the body do something new, only help the body to help itself 1. Cell membrane-embedded enzymes - Fast-acting (ex. Insulin) - increase catalytic activity 2. Ligand-gated ion channels - Concentration gradient (ex. Acetylcholine) - span cell membrane 3. G protein-coupled receptor systems (ex. NE, serotonin, histamine); binding of endogenous ligand or antagonistic drug activates receptors -> G protein -> effector 4. Transcription factors (ex. Steroids) - regulate protein synthesis - Very slow acting, delayed response (hrs -> days) Lock-and-key: If a drug interacts with one type of receptor and that receptor type regulates Lock = receptor only a few processes, the effects of the drug are relatively selective. Non- - Key = drug selective drugs either interact with multiple receptors or one receptor type that - Affinity = fit regulates multiple processes. Selectivity doesn’t guarantee safety. The more - Intrinsic activity = open selective the drug, the more desirable (min. side effects). Receptors are dynamic: With long-term use of drugs the number and sensitivity of receptors can increase/decrease. Dose-response relationship - Increase dose = increase response Three phases: o Bind more receptors 1. Low doses – doesn’t elicit measurable response o Max efficacy 2. Increase dose, increased response (graded) o Allows comparison between medications 3. Increased dose doesn’t increase response Types of Drug-Drug Interactions Pharmacological Non-pharmacological - Based on drug-response interaction - Not predictable - Predictable (side effects, dependence) Alters Blood Level of Drug – Pharmacokinetics Alters Effect of Drug Alters absorption – increases or decreases time/speed of drug Additive – final effect = sum of two drugs - ex. Ion trapping/partitioning – antacid = change pH Potentiative – effect of 1 drug increased by Alters distribution – competing for same receptor another Alters metabolism – ex. Enzymes, inducers Synergistic – final effect > sum of effects nd Alters excretion – change in cardiac output = GFR Antagonistic – 1 drug blocks effect of 2 drug Central Nervous System Pharmacology http://www.youtube.com/watch?v=p5zFgT4aofA http://www.youtube.com/watch?v=u82nzTzL7To&feature=related http://www.youtube.com/watch?v=sc-4zhqViQ4&playnext=1&list=PL5741BFE55F07B035&feature=results_video Neurotransmitters of the CNS All sedatives/hypnotics effect inhibitory neurotransmitter – GABA - Inhibitory (ex. GABA) by either mimicking GABA as an agonist or increasing effect of GABA. - Excitatory (ex. Norepinephrine) - Both (ex. Acetylcholine) ADHD - 3 Types: inattentive, hyperactive-impulsive, combination - Frontal cortex, basal ganglia, brainstem, cerebellum - Neurotransmitters – dopamine, norepinephrine, serotonin - Methylphenidate (Ritalin) – similar to amphetamines o Increases release and prevents re-uptake of NE and dopamine Pharmacotherapy of Depression - SSRI’s - Kinetics o Active metabolite o Long half life o Highly bound to plasma proteins - Effects of fluxoxetine o Immediate – increases 5-HT (serotonin) levels at synapses o 1 month – receptor changes; restore balance of 5-HT and R (receptors) - Adverse effects – decreased sensitivity of serotonin receptors over time Opioids Therapy to Manage Pain - Excitatory neurotransmitters of pain - Opioid analgesics o ex. Substance P, glutamate - decrease neurotransmitter, interfere with substance P - Primary afferent nerve fibers - NSAIDS – decrease prostaglandins o C fibers – Unmyelinated o A-delta fibers – myelinated - Pentazazine Advantages: o Narcotic agonist-antagonists - decreased respiratory depression o If given to someone with opioid dependence - decreased dependence (full agonist), would provide withdrawal symptoms - decreased euphoria o Agonist at kappa Disadvantages: o Antagonist at mu - Increased sedation o Analgesic without respiratory depression - Increased dysphoria - 10% of codeine is converted to morphine in liver - Increased cardiac work o lacking CYP206 -> ineffective o multiple copies CYP206 -> ineffective Benzodiazepine Pharmacology Mechanism - Enhance actions of GABA (inhibitory neurotransmitter); no GABA, no effect - GABA binds at receptor-chloride channel complex o Cl channel opens -> Cl influx - BDZ binds to another site on receptor o Increase frequency of channel opening, increases Cl influx and inhibiting action potential - - When Cl flows into cell, hyperpolarizes, decreases ability to fire (inhibitory) Adverse effects Antagonist - Anterograde amnesia - Flumazenil - Some cross-tolerance with other depressants - May reverse sedative but not respiratory depression Contraindications - Pregnancy (category D) - Lactation – breastmilk - Fetal malformations Over-the-Counter Pain Medications http://www.youtube.com/watch?v=9mculc5O-DE One central mechanism: inhibition of cyclooxygenase (COX), enzyme, responsible for synthesis of prostanoids. Synthesis of PG Aspirin (ASA) Injury - Metabolism: short half-life, converted to active metabolite salicylic acid Arachidonic Acid - Distribution: 80-90% bound to albumin; 10-20% can (released from lipid bilayer) cross the BBB -> enter placenta, breastmilk, etc. - low albumin=toxic effects of drug (elderly, Cyclo-oxygenase (COX) malnourished) Leukotrienes (converts acid to PG) - competition for binding sites -inflammation - Salicylism – overdose (tinnitus, sweating, dizzy) -allergic reactions Prostaglandins - acid-base disturbance -smooth muscle contraction (TXA2, PGI2, PGE2) - Hypersensitivity resembles anaphylaxis - D-D interactions: ACE inhibitors/ARB’s – kidney func Ibuprofen - Contraindications: pregnancy – Cat. C, D in 3 trimest. - COX1 and COX2 inhibitor - risk of bleeding in delivery - Reversi
More Less

Related notes for NURS 2550H

Log In


OR

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit